ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 118 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q3 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $84,000 | +83900.0% | 3,270 | -6.6% | 0.07% | +6.2% |
| Q2 2023 | $100 | -1.0% | 3,500 | -16.7% | 0.06% | -9.7% |
| Q1 2023 | $101 | -99.9% | 4,200 | -35.5% | 0.07% | -10.0% |
| Q4 2022 | $110,494 | +64.9% | 6,515 | +44.1% | 0.08% | +53.8% |
| Q3 2022 | $67,000 | -9.5% | 4,520 | +8.9% | 0.05% | -5.5% |
| Q2 2022 | $74,000 | -31.5% | 4,150 | +3.8% | 0.06% | -17.9% |
| Q1 2022 | $108,000 | -5.3% | 4,000 | +29.4% | 0.07% | -9.5% |
| Q4 2021 | $114,000 | – | 3,090 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DFPG INVESTMENTS, LLC | 183,803 | $9,359,000 | 5.00% |
| DAFNA Capital Management LLC | 229,652 | $9,852,000 | 3.20% |
| HealthCor Management, L.P. | 1,594,452 | $68,402,000 | 2.74% |
| Capital Impact Advisors, LLC | 110,000 | $4,719,000 | 1.40% |
| Cormorant Asset Management, LP | 700,000 | $30,030,000 | 1.16% |
| ARK Investment Management | 2,495,842 | $107,072,000 | 0.64% |
| Millrace Asset Group, Inc. | 18,087 | $776,000 | 0.63% |
| COOPER CREEK PARTNERS MANAGEMENT LLC | 50,532 | $2,168,000 | 0.54% |
| Endurant Capital Management LP | 34,485 | $1,479,000 | 0.44% |
| HealthCor Management, L.P. | 200,000 | $8,580,000 | 0.34% |